Clinical Trial Supply & Logistics Market Outlook, 2025-2032 - A 48 Billion-Dollar Opportunity Featuring Strategic Insights Into 43 Key Companies [Yahoo! Finance]
Here's Why ICON Plc. (ICLR) Gained +20.3% in Q3 [Yahoo! Finance]
Icon (NASDAQ:ICLR) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Icon (NASDAQ:ICLR) was downgraded by analysts at Bank of America Corporation from a "buy" rating to a "neutral" rating. They now have a $195.00 price target on the stock.
Icon (NASDAQ:ICLR) was given a new $200.00 price target on by analysts at Barclays PLC.